CLAIM CARD
Mechanistically, the anti-inflammatory properties of colchicine provide a plausible substrate for longevity benefits through modulation of inflammaging pathways. The cardiovascular findings from Wudexi 2021 and Bian 2026 align with the hypothesis that reducing chronic low-grade inflammation may translate into reduced vascular events, a major determinant of lifespan. Preclinical data and mechanistic human studies support colchicine's role in inhibiting the NLRP3 inflammasome, a key driver of inflammaging, though the translation to clinical longevity endpoints remains inconsistent across populations.
Evidence grade: exploratory
Contradiction status: none
Publication: 873ff54a-3a1e-4c35-b4ff-b2bb5ab68649
Provenance: Derivation Web chain
Citation Support
source_1Mohammadnia 2025source_2Li 2025source_3Ammirati 2026source_4Pascart 2026source_5Broekhoven 2022